FDA Adverse Event Malfunction Summary report: N

MEDRAD VERIS MR VITAL SIGNS MONITOR

MDR report key: 3074879 · Received April 19, 2013

Report

Report Number
2520313-2013-00019
Event Type
Malfunction
Date Received
April 19, 2013
Date of Event
March 25, 2013
Report Date
March 25, 2013
Manufacturer
MEDRAD
Product Code
MHX
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

BAYER R AND I SERVICE REPLACED THE POWER CHARGER AND POWER SUPPLY CABLE. BAYER R AND I PRODUCT ANALYSIS RECEIVED AND EXAMINED THE DC POWER CABLE AND POWER SUPPLY. THE EXAMINATION OF THE LEMO CONNECTOR AND THE ADJOINING WIRES DETERMINED THAT ONE OF THE WIRES HAD CROSSED OVER AND SHORTED WITH ANOTHER CONDUCTOR TO THE POINT WHERE THE INSULATION OF THE TWO CONDUCTORS BECAME CHARRED. A SUBSEQUENT INVESTIGATION OF SIMILAR COMPLAINTS CONCLUDED THAT WHEN CERTAIN COMBINATIONS OF CONDUCTORS SHORT TOGETHER AT THE CABLE END FARTHEST FROM THE POWER SUPPLY, THIS CAN CREATE A CONDUCTION PATHWAY THAT THE POWER SUPPLY DOES NOT RECOGNIZE AS A SHORT CIRCUIT AND SHUT DOWN. CONSEQUENTLY, THE POWER SUPPLY CONTINUES TO ENERGIZE THE CABLE WHICH CAN LEAD TO LOCALIZED HEATING AND MELTING OF THE POWER CABLE. ON (B)(4) 2013, BAYER HEALTHCARE DISTRIBUTED A FIELD SAFETY NOTICE RECALLING ALL 25-FOOT DC POWER CABLES SHIPPED WITH MEDRAD VERIS MR VITAL SIGNS MONITORS, OR THOSE PROVIDED BY BAYER SERVICE. THESE POWER CABLES ARE BEING RECALLED DUE TO A LATENT DESIGN RELIABILITY ISSUE AND THE POTENTIAL FOR SHORTING WHICH CAN RESULT IN HEATING/MELTING OF THE CABLE JACKET.

Description of Event or Problem · 1

THE SITE REPORTED THE FOLLOWING: THE POWER SUPPLY WAS NOT CHARGING THE MONITOR BATTERIES. WHILE ON SITE, A BAYER R AND I SERVICE REP NOTICED THE DC POWER CABLE BECAME VERY HOT TO TOUCH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
168969 MEDRAD VERIS MR VITAL SIGNS MONITOR MONITOR, PHYSIOLOGICAL PATIENT MHX MEDRAD 3011996

Patients

Seq Age Sex Outcome Treatment
1